TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism
- PMID: 11383928
- DOI: 10.1055/s-2001-14942
TSBAb (TSH-stimulation blocking antibody) and TSAb (thyroid stimulating antibody) in TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism
Abstract
There are two types of TSH receptor antibodies (TRAb); thyroid stimulating antibody (TSAb) and TSH-stimulation blocking antibody (TSBAb). TSAb causes Graves' hyperthyroidism. TSBAb causes hypothyroidism. Both TSAb and TSBAb block TSH-binding to thyroid cells as TSH receptor antibodies (TRAb). TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism may have both TSBAb and TSAb. We studied TSBAb and TSAb in 43 TSBAb-positive patients with hypothyroidism and in 55 untreated Graves' patients with hyperthyroidism. TSBAb-activities were expressed as percentage inhibition of bovine (b) TSH-stimulated cAMP production by test IgG. Two formulas were used to calculate TSBAb-activities; TSBAb-A (%) = [1 - (c - b)/(a - b)] x 100 and TSBAb-B (%) = [1 - (c - d)/(a - b)] x 100, where a: cAMP generated in the presence of normal IgG and bTSH, b: cAMP generated in the presence of normal IgG, c: cAMP generated in the presence of test IgG and bTSH, and d: cAMP generated in the presence of test IgG. TSAb (%) = [d/b] x 100. All of the 43 TSBAb-positive patients with hypothyroidism had strongly positive TSBAb-A and -B. Some of them had weakly positive TSAb (<240%). All 55 untreated Graves' patients had positive TSAb (205-2509%). Some of them had both TSAb and TSBAb. TSBAb-positive patients with hypothyroidism had a limited distribution of TSBAb- and TSAb-activities (TSBAb-A + 75 - + 103%, TSBAb-B + 87 - + 106%, TSAb 92-240%), but Graves' patients with hyperthyroidsim had a wide distribution of TSAb- and TSBAb-activities (TSAb 205-2509%, TSBAb-A - 158 - + 43%, TSBAb-B - 14 - + 164%). TSBAb-A ignores TSAb activity in serum, and might give low TSBAb activity. However, TSBAb-A clearly differentiates TSBAb-positive patients with hypothyroidism from Graves' patients with hyperthyroidism; thus, we favor TSBAb-A over TSBAb-B. Some of TSBAb-positive patients with hypothyroidism and Graves' patients with hyperthyroidism have both TSBAb and TSAb.
Similar articles
-
Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.J Thyroid Res. 2012;2012:182176. doi: 10.1155/2012/182176. Epub 2012 May 10. J Thyroid Res. 2012. PMID: 22655217 Free PMC article.
-
Sensitive assay to detect thyroid stimulating antibody (TSAb) in the presence of thyroid stimulation blocking antibody (TSBAb) in serum.Horm Metab Res. 2001 Feb;33(2):115-20. doi: 10.1055/s-2001-12401. Horm Metab Res. 2001. PMID: 11294493
-
Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.Clin Exp Pharmacol Physiol. 2004 May-Jun;31(5-6):314-9. doi: 10.1111/j.1440-1681.2004.03991.x. Clin Exp Pharmacol Physiol. 2004. PMID: 15191404
-
[Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].Nihon Rinsho. 1994 Apr;52(4):1031-6. Nihon Rinsho. 1994. PMID: 7515118 Review. Japanese.
-
Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa.Thyroid. 2013 Jan;23(1):14-24. doi: 10.1089/thy.2012.0374. Thyroid. 2013. PMID: 23025526 Free PMC article. Review.
Cited by
-
Thyrotoxicosis in patients with hypothyroidism is not just overtreatment.BMJ Case Rep. 2017 Jul 14;2017:bcr2017221061. doi: 10.1136/bcr-2017-221061. BMJ Case Rep. 2017. PMID: 28710200 Free PMC article.
-
The Unlikely Suspect: A Case Report of New-Onset Hyperthyroidism Due to Graves' Disease in an 89-Year-Old Gentleman and Review of Literature.Cureus. 2022 Jan 24;14(1):e21546. doi: 10.7759/cureus.21546. eCollection 2022 Jan. Cureus. 2022. PMID: 35106261 Free PMC article.
-
The effect of radioiodine treatment on the characteristics of TRAb in Graves' disease.BMC Endocr Disord. 2021 Nov 30;21(1):238. doi: 10.1186/s12902-021-00905-4. BMC Endocr Disord. 2021. PMID: 34847904 Free PMC article.
-
Changes of TSH-Stimulation Blocking Antibody (TSBAb) and Thyroid Stimulating Antibody (TSAb) Over 10 Years in 34 TSBAb-Positive Patients with Hypothyroidism and in 98 TSAb-Positive Graves' Patients with Hyperthyroidism: Reevaluation of TSBAb and TSAb in TSH-Receptor-Antibody (TRAb)-Positive Patients.J Thyroid Res. 2012;2012:182176. doi: 10.1155/2012/182176. Epub 2012 May 10. J Thyroid Res. 2012. PMID: 22655217 Free PMC article.
-
Sensitivity of assays for TSH-receptor antibodies.J Endocrinol Invest. 2016 Oct;39(10):1195-6. doi: 10.1007/s40618-016-0520-y. Epub 2016 Aug 16. J Endocrinol Invest. 2016. PMID: 27531172 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous